Local recurence of rectal cancer in patients with nonmetastatic disease, diagnosed in 2003 - 2005
Abstract
Background: In the last decades outcomes of rectal cancer treatment are improving due to better understanding of tumor biology, neoadjuvant and adjuvant treatment and precise surgical technique, considering pathologic anatomical lines. Proportion of rectal cancer local recurrence (LR) has been substantially decreasing. Objectives of this study are, first, to find out whether two groups, with and without rectal local recurrence, are statistically important different in certain risk factors and, second, to define prognostic factors of rectal local recurrence.
Methods: Total of 787 nonmetastatisc rectal cancer patients, diagnosed between 2003 and 2005, treated with surgery in all Slovenian hospitals, were enrolled retrospectively. The recurrence-free survival rates were calculated with Kaplan-Meier method. For statistical comparison of survival of two groups according to prognostic factors log-rank test was used. The adjusted hazard ratios for significant survival prognostic factors were calculated using Cox multivariate analysis.
Results: Patients with LR had more tumors in the lower third of rectum (p=0,045), more abdominoperineal, Hartmann's and local excisions (p=0,000) and less radical operations (p=0,005), more of them were operated in hospitals with lesser caseload of patients (p=0,000), more often were treated only surgically (p=0,048), had more colon defects after excision of tumors (p=0,025) and had more distant disease recurrences (p=0,000). In follow up period of 5,3 years LR occurred in 13,1% and in 54% of those in 1,9 years after surgery. In the multivariate analysis, the statistically significant prognostic factors for recurrence-free survival were tumor's rectal position, regional lymph nodes status and the hospital of surgery.
Conclusions: Proportion of LR is an appropriate indicator of optimal multidisciplinary rectal cancer treatment.
Downloads
References
Literatura
Enríquez-Navascués JM, Borda N, Lizerazu A, Placer C, Elosegui JL, Ciria JP, et al. Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol. 2011; 17(13): 1674-84.
Marsh PJ, James RD, Schofield PF. Definition of local recurrence after surgery for rectal carcinoma. Br J Surg. 1995; 82(4): 465-8.
Moore HG, Shoup M, Riedel E, Minsky BD, Alektiar KM, Ercolani M, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum. 2004; 47(10): 1599-606.
Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010; 36(5): 470-6.
Matsuda A, Kishi T, Musso G, Matsutani T, Yokoi K, Wang P, Uchida E. The effect of intraoperative rectal washout on local recurrence after rectal cancer surgery: a meta-analysis. Ann Surg Oncol. 2013; 20(3): 856-63.
Kodeda K, Holmberg E, Jörgren F, Nordgren S, Lindmark G. Rectal washout and local recurrence of cancer after anterior resection. Br J Surg. 2010; 97(10): 1589-97.
Rondelli F, Trastulli S, Cirocchi R, Avenia N, Mariani E, Sciannameo F, Noya G Rectal washout and local recurrence in rectal resection for cancer: a meta-analysis. Colorectal Dis. 2012; 14(11): 1313-21.
Påhlman L, Glimelius B. Local recurrences after surgical treatment for rectal carcinoma. Acta Chir Scand. 1984; 150(4): 331-5.
Pilipshen SJ, Heilweil M, Quan SH, Sternberg SS, Enker WE. Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer. 1984; 53(6): 1354-62.
Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998; 133(8): 894-9.
Enker WE, Merchant N, Cohen AM, Lanouette NM, Swallow C, Guillem J, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg. 1999; 230(4): 544-52.
Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma--experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori. 1995; 81(3 Suppl): 60-4.
Thomas PR, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol. 1988; 13(4): 245-52.
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345(9): 638-46.
Karanjia ND, Corder AP, Bearn P, Heald RJ. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg. 1994; 81(8): 1224-6.
Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg. 1995; 82(8): 1031-3.
Hida J, Yasutomi M, Maruyama T, Fujimoto K, Uchida T, Okuno K. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg. 1997; 184(6): 584-8.
Kim SH, Bae KB, Kim JM, Shin JH, An MS, Ha TG, et al. Oncologic Outcomes and Risk Factors for Recurrence after Tumor-specific Mesorectal Excision of Rectal Cancer: 782 Cases. J Korean Soc Coloproctol. 2012; 28(2): 100-7.
Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, et al. Norwegian Rectal Cancer Group. A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002; 45(7): 857-66.
Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B. Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg. 2005; 92(2): 225-9.
Kapiteijn E, Putter H, van de Velde CJ; Cooperative investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002; 89(9): 1142-9.
Ortiz H, Wibe A, Ciga MA, Lujan J, Codina A, Biondo S; The Spanish Rectal Cancer Project. Impact Of A Multidisciplinary Team Training Programme On Rectal Cancer Outcomes In Spain. Colorectal Dis. 2013; 15(5): 554-51.
Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al, MRC CR07/NCIC-CTG CO16 Trial Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009; 373(9666): 821-8.
Rems M. Vpliv velikosti oddelka na rezultate operativnega zdravljenja raka širokega črevesa in danke II. in III. stadija. Ljubljana:Medicinska fakulteta, 2004.
Markovič S, Repše S, Heijnen S. Obvladovanje kolorektalnega karcinoma. Nacionalna klinična smernica. Projekt razvoja sistema upravljanja zdravstvenega varstva. Ljubljana: Ministrstvo za zdravje; 2002.
Velenik V, Oblak I, Reberšek M, Potrč S, Omejc M, Jelenc F, et al. Smernice za obravnavo bolnikov z rakom debelega črevesa in danke. Onkologija 2011; 15: 18-25.
Jarm K. Podrobna raziskava preživetja bolnikov z rakom danke v Sloveniji, zbolelih v letih 2003-2005. Zdravniška zbornica Slovenije, Specialistična naloga; 2012.
Državni program obvladovanja raka v Sloveniji. 2010. Dostopno na: //www.mz.gov.si/si/zakonodaja_in_dokumenti/dokumenti_strategije_resolucije/
Wittekind C, Compton C, Quirke P, Nagtegaal I, Merkel S, Hermanek P et al. A uniform residual tumor (R) classification. Cancer. 2009; 3483-88.
UICC TNM classification of malignant tumours. Sixth edition. New York: Wiley-Liss; 2002.
Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009; 373(9666): 811-20.
Påhlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjödahl R, et al. The Swedish rectal cancer registry. Br J Surg. 2007 ;94(10): 1285-92.
Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Søreide O. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002; 89(3): 327-34.
Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg. 2004; 240(2): 260-8.
Phang PT, McGahan CE, McGregor G, MacFarlane JK, Brown CJ, Raval MJ, et al. Effects of change in rectal cancer management on outcomes in British Columbia. Can J Surg. 2010; 53(4): 225-31.
Krebs B, Kozelj M, Potrc S. Rectal cancer treatment and survival--comparison of two 5-year time intervals. Coll Antropol. 2012; 36(2): 419-23.
Lim JW, Chew MH, Lim KH, Tang CL. Close distal margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy. Int J Colorectal Dis. 2012;27(10): 1285-94.
Holm T, Cedermark B, Rutqvist LE. Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy. Br J Surg. 1994; 81(3): 452-5.
Kapiteijn E, Marijnen CA, Colenbrander AC, Klein Kranenbarg E, Steup WH, van Krieken JH, et al. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol. 1998; 24(6): 528-35.
McDermott FT, Hughes ES, Pihl E, Johnson WR, Price AB. Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patients. Br J Surg. 1985; 72(1): 34-7.
Latosinsky S, Turner D. Local recurrence after rectal cancer treatment in Manitoba. Can J Surg. 2009 Feb;52(1):45-50.
Phang PT, Woods R, Brown CJ, Raval M, Cheifetz R, Kennecke H. Effect of systematic education courses on rectal cancer treatments in a population. Am J Surg. 2011; 201(5): 640-4.
Peng J, Sheng W, Huang D, Venook AP, Xu Y, Guan Z, Cai S. Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect. Cancer. 2011;117(7): 1415-21.
Mroczkowski P, Hać S, Mik M, Berut M, Dziki Ł, Kube R, et al. Preliminary results of the first quality assurance project in rectal cancer in Poland. Pol Przegl Chir. 2011; 83(3):144-9.
Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer.. Ann Surg Oncol. 2007; 14(2): 447-54.
van de Velde CJ, Aristei C, Boelens PG, Beets-Tan RG, Blomqvist L, Borras JM, et al. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe. Eur J Cancer. 2013; 49(13): 2784-90.
Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 2000; 356(9224): 93-6.
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345(9): 638-46.
Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007; 246(5): 693-701.
van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; 12(6): 575-82.
Glimelius B. Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future. Ups J Med Sci. 2012; 117(2): 225-36.
Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986; 1(8496): 1479-82.
Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, et al. Standards Practice Task Force; American Society of Colon and Rectal Surgeons.Practice parameters for the management of rectal cancer (revised). Dis ColonRectum. 2005; 48(3): 411-23.
Simunovic M, Coates A, Goldsmith CH, Thabane L, Reeson D, Smith A, et al. The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery. CMAJ.2010; 182(12): 1301-6.
Herzog T, Belyaev O, Chromik AM, Weyhe D, Mueller CA, Munding J, et al. TME quality in rectal cancer surgery. Eur J Med Res. 2010; 15: 292-6.
Hermanek P, Hermanek P, Hohenberger W, Klimpfinger M, Köckerling F, Papadopoulos T. The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis. 2003; 18(4): 335-41.
Engel J, Kerr J, Eckel R, Günther B, Heiss M, Heitland W, et al. Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol. 2005; 31(5): 512-20.
Ptok H, Marusch F, Kuhn R, Gastinger I, Lippert H. Influence of hospital volume on the frequency of abdominoperineal resection and long-term oncological outcomes in low rectal cancer. Eur J Surg Oncol. 2007; 33(7): 854-61.
Manchon-Walsh P, Borras JM, Espinas JA, Aliste L et Catalonian Rectal Cancer Group. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. Eur J Surg Oncol. 2011; 37(4): 325-33.
Mack LA, Temple WJ. Education is the key to quality of surgery for rectal cancer. Eur J Surg Oncol. 2005; 31(6): 636-44.
Kolfschoten NE, Marang van de Mheen PJ, Gooiker GA, Eddes EH, Kievit J, Tollenaar RA, Wouters MW; Dutch Surgical Colorectal Audit group. Variation in case-mix between hospitals treating colorectal cancer patients in the Netherlands. Eur J Surg Oncol. 2011; 37(11): 956-63.
Kolfschoten NE, Marang-van de Mheen PJ, Wouters MW, Eddes EH, Tollenaar RA, Stijnen T, Kievit J; Dutch Surgical Colorectal Audit Group. A combined measure of procedural volume and outcome to assess hospital quality of colorectal cancer surgery, a secondary analysis of clinical audit data. PLoS One. 2014; 9(2): e88737.
Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol. 2003; 4(11): 695-702.
Huh JW, Kim YJ, Kim HR Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer. Ann Surg. 2012; 255(1): 70-8.
Persiani R, Biondi A, Gambacorta MA, Bertucci Zoccali M, Vecchio FM, Tufo A, et al. Prognostic implications of the lymph node count after neoadjuvant treatment for rectal cancer. Br J Surg. 2014; 101(2): 133-42.
Lee WS, Lee SH, Baek JH, Lee WK, Lee JN, Kim NR, Park YH. What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer. Radiat Oncol. 2013; 8(1): 202.
de Campos-Lobato LF, Stocchi L, de Sousa JB, Buta M, Lavery IC, Fazio VW, et al. Less than 12 nodes in the surgical specimen after total mesorectal excision following neoadjuvant chemoradiation: it means more than you think! Ann Surg Oncol. 2013; 20(11): 3398-406.
Maslekar S, Sharma A, Macdonald A, Gunn J, Monson JR, Hartley JE. Mesorectal grades predict recurrences after curative resection for rectal cancer. Dis Colon Rectum. 2007; 50(2): 168-75.
Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002; 20(7): 1729-34.
Kaiser AM, Klaristenfeld D, Beart RW. Preoperative versus postoperative radiotherapy for rectal cancer in a decision analysis and outcome prediction model. Ann Surg Oncol. 2012; 19(13): 4150-60.
Senapati A, O'Leary DP, Flashman KG, Parvaiz A, Thompson MR. Low rates of local recurrence after surgical resection of rectal cancer suggest a selective policy for preoperative radiotherapy. Colorectal Dis. 2012; 14(7): 838-43.
van Gijn W, van de Velde CJ; members of the EURECCA consortium. Improving quality of cancer care through surgical audit. Eur J Surg Oncol. 2010; 36(1Suppl): 23-6.
van Gijn W, van de Velde CJ. 2010 SSO John Wayne clinical research lecture: rectal cancer outcome improvements in Europe: population-based outcome registrations will conquer the world. Ann Surg Oncol. 2011; 18(3): 691-6.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
